Meningitis Shot Fails to Stop Gonorrhea Among Men

A recent study finds that the meningococcal B vaccine 4CMenB does not reduce gonorrhea transmission among men who have sex with men (MSM).

Study Design

• Participants: Over 600 MSM, split evenly between vaccine and placebo groups.
• Duration: Two years of follow‑up.

Key Findings

The identical infection rates indicate no protective effect from the vaccine.

Expert Commentary

“The data clearly show that 4CMenB offers no protection against this infection,” says lead scientist Kate Seib of Griffith University.

Context & Implications

• No current vaccine exists for gonorrhea.
• Antibiotic‑resistant strains are increasing in prevalence.
• Earlier studies suggesting a 38 % reduction likely had uncontrolled confounding factors.

Practical Take‑aways

• 4CMenB remains safe and effective against certain meningitis strains.
• MSM should continue to use condoms and undergo regular STI screening to prevent gonorrhea.

Publication Status

The findings were first presented at a Denver conference and will appear in peer‑reviewed literature shortly.